ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu
ALS Research Collaboration
  • Home
  • Learn ⇓
    • ALS Glossary of Terms
    • Frequently Asked Questions
    • About Familial ALS
  • Research Studies
  • Get Involved ⇓
    • Join a Study
    • Contact Us
    • US Clinical Trial Map
    • Newsletter
    • Support Our Research
  • About Us ⇓
    • Our Journey
    • Core Members
  • Search
  • Menu

CRiALS Genetics

About the Study

Principal investigator: Michael Benatar, MD, PhD

Interpreting Dna GelThe CRiALS Genetics study is aimed at increasing our understanding the genetic causes of ALS and related disorders; helping us to identify individuals who are at a genetic risk for developing these disease; and thereby to work towards developing new therapies for individuals with ALS and/or who are at risk for developing disease. Eligible participants submit a blood sample, which can be collected at our research site or remotely by mail. The sample collected is then sent for genetic testing. Results of genetic testing are only provided to affected individuals.

Eligibility Criteria

Eligible Participants include:

  • Individuals affected with neurological disease that may be caused by a genetic abnormality
  • Individuals with a family history of neurological disease
  • Individuals with no neurological disease nor indication of family history disease
Funding Agencies

ALS_recovery_find_Logo
ALS Recovery Fund

Collaborators
  • Peter Andersen, MD, DMSc (Umea University, Sweden)
  • Christine Stanislaw, MS (Emory University)
  • Paul Tayler, MD, PhD (St. Jude Children’s Hospital)
  • Stephan Züchner, MD, PhD (University of Miami)
Contact

Research coordinators:

  • Catalina Fernandez
  • Danielle Dauphin
  • Katja McBane

Contact information:

  • Email: fals@med.miami.edu
  • Phone: 1-888-413-9315
Links
Publications
  • Nordin A, Akimoto C, Wuolikainen A, Nordin F, Alstermark H, Forsberg K, Baumann P, Pinto S, de Carvalho M, Hübers A-M, Ludolph A, Weishaupt J, Meyer T, Grehl T, Schweikert K, Weber M, Burkhardt C, Neuwirth C, Holmøy T, Morita M, Tysnes O-B, Benatar M, Wuu J, Lange D, Bisgård C, Asgari N, Tarvainen I, Brännström T, Andersen PM. Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: A large multinational screening study. Amyotroph Lateral Scler Frontotemporal Degener. 2016 Dec 12:1-9. [Epub ahead of print]
  • Benatar M, Stanislaw C, Reyes E, Hussain S, Cooley A, Fernandez MC, Dauphin D, Michon SC, Andersen PM, Wuu J. Pre-Symptomatic ALS Genetic Counseling and Testing: Experience and Recommendations.  Neurology, 86(24): 2295-302, 2016.  [ Pubmed Link ] PMID: 27194384
  • Johnson JQ, Mandrioli J, Benatar M, et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010 Dec 9;68(5):857-64. [ Pubmed Link ]
  • Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011 Oct 20;72(2):257-68. [ Pubmed Link ]
  • Kim HJ, Kim NC, Wang YD, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013 Mar 28;495(7442):467-73. [ Pubmed Link ]

Back to Research Studies

Active Research Studies

  • Research Studies (All)
  • Pre-fALS
  • CReATe PGB
  • PRESS-ALS
  • CRiALS Biomarker
  • CRiALS Genetics
  • Neuraltus NP001

Contact Us

By phone:
For familial ALS and general inquiries:
1-888-413-9315
For the CReATe Consortium and related studies:
1-844-837-1031

By email:
fals@miami.edu (For familial ALS inquiries)
projectcreate@miami.edu (For CReATe inquiries)
alsresearch@miami.edu (General inquiries)

Support Our Research

Affiliates

  • CReATe Consortium
  • CReATe Connect
  • The Kessenich Family ALS Center at UM
  • ALS Recovery Fund
  • ALS Association
  • Muscular Dystrophy Association
  • CDC National ALS Registry
  • The Northeastern ALS Consortium
  • Myasthenia Gravis Research Group
Read Our Newsletter

News

  • Biomarker for ALS Disease Progression Identified by the Teams at University of Miami and Flinders University!03/07/2017 - 5:48 pm
  • Brain MedicineDr. Benatar presents promising phase II trial results of Arimoclomol in SOD1 ALS12/09/2016 - 5:02 pm
  • CReATe Consortium Virtual Journal Club12/08/2016 - 3:18 pm
More News
© Copyright - ALS Research Collaboration. Site by Academic Web Pages
Scroll to top
Translate »